Molina J-M, et al. Doravirine (DOR) versus ritonavir-boosted darunavir (DRV+r): 96-week results of the randomized, double-blind, phase 3 DRIVE-FORWARD Noninferiority trial. AIDS 2018.
Effect van onderbreking methotrexaat op de immuniteit na de COVID-19-booster
jan 2023 | Psoriasis, RA, Vaccinatie, Virale infecties